Growing Focus On The Development And Launch Of Generic Naloxone Nasal Spray Products Driving Growth In The Naloxone Market

Naloxone Market
The global Naloxone Market is estimated to be valued at US$ 1234.6 Mn in 2023 and is expected to exhibit a CAGR of 10. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Naloxone is an opiate antagonist used to treat narcotic overdoses. It can reverse the effects of overdose of heroin, oxycodone, hydrocodone, and other narcotics. Naloxone is available in injectable and nasal spray forms.

Market key trends:
One of the key trends in the naloxone market is the growing focus on the development and launch of generic naloxone nasal spray products. Nasal naloxone has an ease of administration and is driving the demand for overdose rescue. For instance, in May 2021, Pfizer Inc. launched generic naloxone nasal spray under the brand name Naloxone HCI Nasal Spray for use as an emergency treatment of known or suspected opioid overdose.

Segment Analysis
The global naloxone market is segmented into product and distribution channel. Based on product, the naloxone market is segmented into auto-injectors, prefilled syringes and others. The auto-injectors segment dominates the global naloxone market owing to its ease of use and safety features. Auto-injectors eliminate the risk of needle stick injuries and permits quick administration of naloxone in the event of an opioid overdose emergency.

Key Takeaways
The global naloxone market analysis is expected to witness high growth, exhibiting CAGR of 10.% over the forecast period, due to increasing prevalence of opioid overdose cases.

Regional analysis
North America dominates the global naloxone market owing to high prevalence of opioid overdose deaths in the US and Canada. The region is expected to continue its dominance over the forecast period owing to continued efforts by governments to increase access to naloxone products through public health programmes and Good Samaritan laws.

Key players
Key players operating in the naloxone market are Viatris Inc., Opiant Pharmaceuticals, Akorn Operating Company LLC, Pfizer, Inc., Novartis AG, Indivior Plc., Emergent BioSolutions Inc., Amphastar Pharmaceuticals, Inc., Kern Pharma, S.L., Hikma Pharmaceuticals PLC, Mundipharma International Limited, and Kaleo, Inc.

Comments

Post a Comment

Popular posts from this blog

Feminine Hygiene Products Market Growth Accelerated By Rising Awareness About Women Hygiene

Image
Feminine Hygiene Products Market    Feminine hygiene products provide effective solutions for maintaining women's intimate hygiene and offer convenience during menstrual cycles. Sanitary pads, tampons, panty liners, and menstrual cups are commonly used feminine hygiene products that efficiently absorb menstrual blood flow. The growing awareness about women's hygiene and health and availability of innovative product varieties catering to different needs have accelerated the demand for these products. Factors such as changing lifestyles and rising incomes have further contributed to the increased spending on intimate healthcare needs of women. The global Feminine Hygiene Products Market is estimated to be valued at US$ 41.71 Bn in 2024 and is expected to exhibit a CAGR of 23.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth in the feminine hygiene products...
Read more

The Global Naloxone Market Is Set To Experience Exponential Growth Owing To Rising Opioid Overdoses

Image
   naloxone market The naloxone market has experienced significant growth in recent years owing to increasing cases of opioid overdoses across the globe. Naloxone is an opioid antagonist medication used to reverse the effects of opioid overdoses including life-threatening depression of central nervous system and respiratory functions. The global naloxone market is estimated to be valued at US$ 1,422.26 million in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period of 2024-2030. Naloxone is administered as an injection into a muscle or vein or as a nasal spray. It is effective against both natural and synthetic opioids such as morphine, heroin, oxycodone, fentanyl, and methadone. Rising abuse and misuse of prescription opioids and increasing societal acceptability of opioids for pain management have been identified as major causes of opioid epidemics in many countries. Moreover, governmental support through policy and funding initiatives for wider public...
Read more

The Global Antimicrobial Plastics Market Growth Accelerated By Increased Safety Measures

Image
Antimicrobial Plastics Market   Antimicrobial plastics are a range of plastics that are incorporated with antimicrobial additives which make them capable of destroying microbes and bacteria. They help reduce the growth and spread of microbes and are highly effective against pathogens. These plastics find wide usage in healthcare, packaging, food and beverage industries due to their ability to inhibit microbial growth. The global Antimicrobial Plastics Market is estimated to be valued at US$ 37.35 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increased usage of antimicrobial plastics can be attributed to the rising safety measures across industries. With growing awareness regarding hygiene and safety, antimicrobial plastics are being increasingly used in applications such as food packaging, healthcare and medical devices. Their effecti...
Read more